Alkem Laboratories Announcements
Newspaper Advertisement- Disclosure under Regulation 30
14 Nov, 2025 | 04:10pm • Source: BSE
Please find enclosed herewith the details of the Analyst / Institutional Investor meetings.
14 Nov, 2025 | 03:58pm • Source: BSE
Closure of EU GMP inspection by German Health Authority at Alkem''s manufacturing facility located at Baddi, India
10 Nov, 2025 | 07:00pm • Source: BSE
Pursuant to Regulation 30 read with SEBI LODR regulations, this is to inform you that the Company has received order passed by statutory authority under...
03 Nov, 2025 | 04:17pm • Source: BSE
Press Release- Alkem Foundation and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines
03 Nov, 2025 | 02:17pm • Source: BSE
Press Release - Alkem and IIT Bombay announce strategic collaboration to set up advanced research centre for immuno-therapeutics and regenerative medicines.
03 Nov, 2025 | 01:03pm • Source: BSE
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss...
28 Oct, 2025 | 04:11pm • Source: BSE
Pursuant to Regulation 30 read with SEBI LODR Regulations, this is to inform you that the Company has received an appeal order passed by statutory...
01 Oct, 2025 | 03:11pm • Source: BSE
This is to inform you that today i.e. 26th September, 2025, the Company has entered into a Business Transfer Agreement with Alkem Wellness Limited, a...
26 Sep, 2025 | 05:28pm • Source: BSE
This is to inform you that the trading window will remain closed from 29th September, 2025 until the expiry of 48 hours after the date...
25 Sep, 2025 | 03:50pm • Source: BSE
This is to inform you that Mr. Amit Ghare, a Senior Management Personnel has tendered his resignation from the services of the Company on account...
25 Sep, 2025 | 03:29pm • Source: BSE
Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Company has received an order passed by the statutory authority...
24 Sep, 2025 | 02:30pm • Source: BSE
Pursuant to Regulation 30 of SEBI LODR Regulation, 2015, this is to inform you that the Company has received an order passed by the statutory...
22 Sep, 2025 | 08:30pm • Source: BSE
This is to intimate you that Alkem Laboratories Limited (the 'Company') launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A...
22 Sep, 2025 | 04:04pm • Source: BSE
Please find enclosed herewith the details of investor meetings scheduled to be held on 25th September, 2025, 26th September, 2025 and 30th September, 2025.
18 Sep, 2025 | 12:39pm • Source: BSE
Please find enclosed herewith the details of investor meeting scheduled to be held on 22nd September, 2025.
17 Sep, 2025 | 03:49pm • Source: BSE
Please find enclosed herewith the details of investor meetings scheduled to be held on 22nd September, 2025 and 25th September, 2025.
16 Sep, 2025 | 06:58pm • Source: BSE
In continuation to our intimation dated 03rd September, 2025, this is to inform that, the Analyst / Investor meeting as scheduled to be held on...
09 Sep, 2025 | 12:28pm • Source: BSE
Alkem Laboratories Limited has informed the Exchange about Schedule of meet
08 Sep, 2025 | 12:38pm • Source: NSE
Please find enclosed herewith the details of investor meetings scheduled to be held on 12th September, 2025, 17th September, 2025, 18th September, 2025, 19th September,...
08 Sep, 2025 | 12:28pm • Source: BSE